What’s on the horizon to tackle unmet needs in recurrent metastatic SCCHN?

28/02/2024 34 min Episodio 351
What’s on the horizon to tackle unmet needs in recurrent metastatic SCCHN?

Listen "What’s on the horizon to tackle unmet needs in recurrent metastatic SCCHN?"

Episode Synopsis

touchEXPERT OPINIONS for touchONCOLOGY
Three experts share insights into the unmet treatment needs for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the rationale for developing additional immunotherapy-based strategies and targeted therapies, and the latest data and ongoing trials for these investigational approaches. 
The experts
Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil
Prof. Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan
Dr Ranee Mehra - Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA

This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an independent medical educational grant from Seagen Inc. and Genmab US, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/future-treatment-of-recurrent-metastatic-scchn/ 

More episodes of the podcast touchPODCAST